James Toy is an associate in the firm’s San Francisco office. He represents high tech companies in licensing and collaboration transactions as well as general corporate matters. Prior to joining Covington, he conducted life sciences research at St. Jude Children’s Research Hospital and MIT, and he held various positions at leading global law firms, numerous startups, and a venture capital firm.
Publications and Speeches
- "Ozz-E3, a Muscle-Specific Ubiquitin Ligase, Regulates Beta-Catenin Degradation During Myogenesis," Developmental Cell (2004), Co-Author
- "Targeting Macrophages with Baculovirus-Produced Lysosomal Enzymes: Implications for Enzyme Replacement Therapy of the Glycoprotein Storage Disorder Galactosialidosis," FASEB Journal (2004), Co-Author